These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30592192)

  • 21. Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty.
    Neely EK; Wilson DM; Lee PA; Stene M; Hintz RL
    J Pediatr; 1995 Jul; 127(1):47-52. PubMed ID: 7608810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathophysiology of gonadotropin secretion in patients with idiopathic precocious puberty and follow up studies during and after therapy with medroxyprogesterone acetate (author's transl)].
    Aono T; Minagawa J; Terakawa N; Kurachi K; Matsumoto K
    Nihon Naibunpi Gakkai Zasshi; 1975 Nov; 51(11):898-907. PubMed ID: 1241847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved final predicted height with the injection of leuprolide in children with earlier puberty: A retrospective cohort study.
    Lin YC; Lin CY; Chee SY; Yen HR; Tsai FJ; Chen CY; Wang CH
    PLoS One; 2017; 12(10):e0185080. PubMed ID: 28973010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of leuprolide acetate administered monthly compared to three-monthly in the treatment of central precocious puberty: evaluation at the end of treatment.
    Thaneetrakool T; Aroonparkmongkol S; Numsriskulrat N; Supornsilchai V; Wacharasindhu S; Srilanchakon K
    Front Endocrinol (Lausanne); 2024; 15():1390674. PubMed ID: 38737553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overnight luteinizing and follicle stimulating hormone profiles during GnRHa treatment in short girls born small for gestational age.
    van der Kaay DC; de Jong FH; Laven JS; Hokken-Koelega AC
    J Pediatr Endocrinol Metab; 2009 Feb; 22(2):161-9. PubMed ID: 19449673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal assessment of auxological parameters, adult height outcome and its determinants in leuprolide-treated Indian girls with idiopathic central precocious puberty.
    Mondkar S; Khadilkar V; Yewale S; Dange N; More C; Khadilkar A
    J Pediatr Endocrinol Metab; 2024 Jan; 37(1):62-68. PubMed ID: 38008794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Final adult height in children with central precocious puberty - a retrospective study.
    Knific T; Lazarevič M; Žibert J; Obolnar N; Aleksovska N; Šuput Omladič J; Battelino T; Avbelj Stefanija M
    Front Endocrinol (Lausanne); 2022; 13():1008474. PubMed ID: 36531464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of subcutaneous administration of gonadotropin-releasing hormone agonist on idiopathic central precocious puberty.
    Liang Y; Wei H; Zhang J; Hou L; Luo X
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):558-61. PubMed ID: 17219967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of leuprorelin 3-month depot (11.25 mg) for idiopathic central precocious puberty treatment of Chinese girls: a single-center retrospective study.
    Huang S; Zhang L; Gao C; Ou H; Hou L; Liu Z; Wang D; Xu Y; Liang L; Meng Z
    J Pediatr Endocrinol Metab; 2024 Jan; 37(1):15-20. PubMed ID: 37975727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of central precocious puberty treatment with GnRH analogue at the Triangulo Mineiro Federal University (UFTM).
    Borges Mde F; Franciscon Pde M; Cambraia TC; Oliveira DM; Ferreira BP; Resende EA; Palhares HM
    Arch Endocrinol Metab; 2015 Dec; 59(6):515-22. PubMed ID: 26421668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presentation of 493 consecutive girls with idiopathic central precocious puberty: a single-center study.
    Giabicani E; Allali S; Durand A; Sommet J; Couto-Silva AC; Brauner R
    PLoS One; 2013; 8(7):e70931. PubMed ID: 23936254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring treatment of central precocious puberty using basal luteinizing hormone levels and practical considerations for dosing with a 3-month leuprolide acetate formulation.
    Lee PA; Luce M; Bacher P
    J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1249-1257. PubMed ID: 27740929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The usefulness of the leuprolide stimulation test as a diagnostic method of idiopathic central precocious puberty in girls.
    Carretto F; Salinas-Vert I; Granada-Yvern ML; Murillo-Vallés M; Gómez-Gómez C; Puig-Domingo M; Bel J
    Horm Metab Res; 2014 Dec; 46(13):959-63. PubMed ID: 25295414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR; Aceto T; Weber C; Pang S
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of medroxyprogesterone acetate on gonadotropin secretion in girls with precocious puberty.
    Warren MP; Mathews JH; Morishima A; Vande Wiele R
    Am J Med Sci; 1975; 269(3):375-81. PubMed ID: 1155493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Levels of Thyroid Stimulating Hormone and Luteinizing Hormone Are Decreased in Girls with Central Precocious Puberty after 12-Month GnRH Agonist Treatment.
    Kim YJ; Chung LY; Kang E; Nam HK; Rhie YJ; Lee KH
    Tohoku J Exp Med; 2020 Nov; 252(3):193-197. PubMed ID: 33087637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy.
    Bhatia S; Neely EK; Wilson DM
    Pediatrics; 2002 Feb; 109(2):E30. PubMed ID: 11826240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Comparison of Patients with Central Precocious Puberty Who Have a Pubertal versus Prepubertal Ultrasensitive LH at Presentation.
    Logan LA; Eugster EA
    Horm Res Paediatr; 2020; 93(11-12):651-655. PubMed ID: 33765678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of sex steroids by a gonadotrophin-releasing hormone agonist increases serum growth hormone-binding protein activity in girls with central idiopathic precocious puberty.
    Kobayashi Y; Murata A; Yasuda T; Minagawa M; Wataki K; Ohnishi H; Niimi H
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):351-5. PubMed ID: 8187298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of gonadotropin-releasing hormone analog on ovarian reserve in children with central precocious puberty.
    Tao Y; Si C; Li H; Han J; Hou H; Yang M
    Ann Palliat Med; 2020 Jan; 9(1):53-62. PubMed ID: 32005063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.